Use 'TKI as Long as You Can' in NSCLC

Two studies presented at ESMO 2014 clarify the sequence of therapies after disease progression in EGFR-mutated non-small cell lung cancer.

Source: Medscape Oncology - October 6, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts